Melatonin and neuroblastoma: a novel therapeutic approach.

Mohammad Hossein Pourhanifeh, Mahboobeh Kamali, Saeed Mehrzadi, Azam Hosseinzadeh

Journal: Molecular biology reports 2021;48(5):4659-4665

PMID: 34061325

Abstract

Neuroblastoma is a deadly and serious malignancy among children. Although many developments have been occurred for the treatment of this disease, the rate of mortality is still high. Therefore, it is necessary to search for novel complementary and alternative therapies. Melatonin, a hormone secreted from pineal gland, is a multifunctional agent having anticancer potentials. Recently, several investigations have been conducted indicating melatonin effects against neuroblastoma. In this paper, we summarize current evidence on anti-neuroblastoma effects of melatonin based on cellular pathways.

Address: Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.; Central Library, Iran University of Medical Sciences, Tehran, Iran.; Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.; Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran. [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.